Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.

Matsushita K, Kwak L, Sang Y, Ballew SH, Skali H, Shah AM, Coresh J, Solomon S.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e006259. doi: 10.1161/JAHA.117.006259.

2.

Risk-Based Triage for Nephrology Referrals Using the Kidney Failure Risk Equation.

Hingwala J, Wojciechowski P, Hiebert B, Bueti J, Rigatto C, Komenda P, Tangri N.

Can J Kidney Health Dis. 2017 Aug 9;4:2054358117722782. doi: 10.1177/2054358117722782. eCollection 2017.

4.

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.

Gonzalez-Calero L, Martin-Lorenzo M, de la Cuesta F, Maroto AS, Baldan-Martin M, Ruiz-Hurtado G, Pulido-Olmo H, Segura J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Cardiovasc Diabetol. 2016 Jan 16;15:8. doi: 10.1186/s12933-016-0331-7.

5.

Factors Associated with Unplanned Dialysis Starts in Patients followed by Nephrologists: A Retropective Cohort Study.

Brown PA, Akbari A, Molnar AO, Taran S, Bissonnette J, Sood M, Hiremath S.

PLoS One. 2015 Jun 5;10(6):e0130080. doi: 10.1371/journal.pone.0130080. eCollection 2015.

6.

Cause of Death in Patients with Reduced Kidney Function.

Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M; Alberta Kidney Disease Network.

J Am Soc Nephrol. 2015 Oct;26(10):2504-11. doi: 10.1681/ASN.2014070714. Epub 2015 Mar 2.

7.

Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.

Zhan Y, Yang L, Wen Y, Liu H, Zhang H, Zhu B, Han W, Gu Y, Sun X, Dong X, Zhao T, Ma H, Li P.

Evid Based Complement Alternat Med. 2014;2014:375986. doi: 10.1155/2014/375986. Epub 2014 May 21.

8.

Cardiovascular complications of diabetic kidney disease.

Pálsson R, Patel UD.

Adv Chronic Kidney Dis. 2014 May;21(3):273-80. doi: 10.1053/j.ackd.2014.03.003. Review.

9.

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).

Haynes R, Staplin N, Emberson J, Herrington WG, Tomson C, Agodoa L, Tesar V, Levin A, Lewis D, Reith C, Baigent C, Landray MJ; SHARP Collaborative Group.

Am J Kidney Dis. 2014 Jul;64(1):40-8. doi: 10.1053/j.ajkd.2013.12.013. Epub 2014 Mar 5.

10.

Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey.

Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, Rhee BD, Kim DJ.

PLoS One. 2013 Dec 27;8(12):e83273. doi: 10.1371/journal.pone.0083273. eCollection 2013.

11.

Predictors of end-stage renal disease in the urban poor.

Hall YN, Choi AI, Xu P, Smith NL, Boyko EJ.

J Health Care Poor Underserved. 2013 Nov;24(4):1686-700. doi: 10.1353/hpu.2013.0189.

12.

Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.

Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N.

Am J Kidney Dis. 2013 Dec;62(6):1102-8. doi: 10.1053/j.ajkd.2013.07.013. Epub 2013 Sep 14.

13.

Transforming growth factor-beta and the glomerular filtration barrier.

Ghayur A, Margetts PJ.

Kidney Res Clin Pract. 2013 Mar 1;32(1):3-10.

14.

Proteinuria and rate of change in kidney function in a community-based population.

Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R, Jun M, Klarenbach S, Hemmelgarn BR.

J Am Soc Nephrol. 2013 Oct;24(10):1661-7. doi: 10.1681/ASN.2012111118. Epub 2013 Jul 5.

15.

Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study.

Chang A, Batch BC, McGuire HL, Vollmer WM, Svetkey LP, Tyson CC, Sanguankeo A, Anderson C, Houston J, Appel LJ.

Am J Kidney Dis. 2013 Nov;62(5):900-7. doi: 10.1053/j.ajkd.2013.04.022. Epub 2013 Jun 28.

16.

Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.

Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A.

CMAJ. 2013 Jun 11;185(9):E417-23. doi: 10.1503/cmaj.120833. Epub 2013 May 6.

17.

Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study.

Chang A, Van Horn L, Jacobs DR Jr, Liu K, Muntner P, Newsome B, Shoham DA, Durazo-Arvizu R, Bibbins-Domingo K, Reis J, Kramer H.

Am J Kidney Dis. 2013 Aug;62(2):267-75. doi: 10.1053/j.ajkd.2013.02.363. Epub 2013 Apr 17.

18.

Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.

Erickson KF, Lea J, McClellan WM.

Clin J Am Soc Nephrol. 2013 Jan;8(1):75-81. doi: 10.2215/CJN.03340412. Epub 2012 Oct 18.

19.

Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women.

Lewis JR, Lim W, Dhaliwal SS, Zhu K, Lim EM, Thompson PL, Prince RL.

BMC Nephrol. 2012 Jul 16;13:58. doi: 10.1186/1471-2369-13-58.

20.

Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants.

Crews DC, McClellan WM, Shoham DA, Gao L, Warnock DG, Judd S, Muntner P, Miller ER, Powe NR.

Am J Kidney Dis. 2012 Nov;60(5):779-86. doi: 10.1053/j.ajkd.2012.05.010. Epub 2012 Jun 12.

Supplemental Content

Support Center